M1. Manipulation of Blood and Blood Components
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
The following are prohibited:
- The administration or reintroduction of any quantity of autologous, homologous or heterologous blood or red blood cell products of any origin into the circulatory system.
- Artificially enhancing the uptake, transport or delivery of oxygen, including, but not limited to, perfluorochemicals, efaproxiral (RSR13) and modified haemoglobin products (e.g. haemoglobin-based blood substitutes, microencapsulated haemoglobin products), excluding supplemental oxygen.
- Any form of intravascular manipulation of the blood or blood components by physical or chemical means.